AADI (Aadi Bioscience) Wutah bathi ing taun lumaku

Simbol resmi perusahaan Aadi Bioscience, Inc. (AADI)

Optimized express logistics for pharmaceuticals are driving momentum, as confirmed by the 12-month relative EPS growth rate; the value 78.50 represents the current metric. The fundamental basis of Aadi Bioscience (AADI) is the unique Fyarro therapy for rare tumors. Robotic cell screening, which minimizes headcount, enhances development efficiency. Certified air corridors ensure the precision of drug delivery.

AADI (Aadi Bioscience Inc) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 19.03.2025

Rincian metrik komprehensif lan analitis aadibio.com (AADI)

- rega saham lan prakiraan rega para ahli:
Rega Aadi Bioscience, Inc.|AADI - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar AADI|AADI - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham Aadi Bioscience|AADI - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas aadibio.com|AADI - Total Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Aadi Bioscience|AADI - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Aadi Bioscience, Inc.|AADI - Gunggung utang perusahaan|Utang-utang marang nilai buku AADI|AADI - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Aadi Bioscience|Rasio jangkoan perantara aadibio.com
- indikator pendapatan resik lan kelipatan nilai:
AADI - Penghasilan resik|Bathi resik mangsa ngarep Aadi Bioscience|AADI - Pangali P/E|Pangali mangsa ngarep rega marang bathi Aadi Bioscience, Inc.|AADI - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AADI|AADI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Aadi Bioscience|AADI - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan aadibio.com|AADI - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Aadi Bioscience
Pambiji fundamental:AADI Aadi Bio
Produk mawa merek Aadi Bioscience

Geopolitical fragmentation and the disruption of supply chains significantly hinder the conduct of international clinical trials for Aadi Bioscience (AADI). By analyzing the year-over-year percentage growth in net income per share, investors assess business efficiency dynamics relative to the previous period. This metric calculates the percentage difference between current and prior EPS, determining the company's ability to generate income amidst external risks and its operational resilience.

Pesaing langsung

GMAB: Wutah bathi resik saben siji saham kanggo taun lumaku|EXEL (Exelixis Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Nuvalent Therapeutics|Wutah bathi saben saham ing taun lumaku Kymera Therapeutics (KYMR)|IDYA (ideayabio.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ELVN (Enliven Therapeutics, Inc.)|Owah-owahan bathi resik saben saham ing taun lumaku ORIC Pharmaceuticals Inc|Relay Pharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Wutah bathi resik saben saham ing taun iki|VSTM: Wutah bathi resik saben siji saham kanggo taun lumaku|GLUE (Monte Rosa Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Cullinan Oncology CGEM|Wutah bathi ing taun lumaku IMRX|C4 Therapeutics Corp - Wutah bathi saben saham ing taun iki|Black Diamond - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku RPTX|PMVP: Wutah bathi resik saben saham ing taun iki|Karyopharm Therapeutics - Wutah bathi resik saben siji saham kanggo taun lumaku|PPCB: Wutah bathi ing taun lumaku|Cyclacel - Tambahing bathi saben saham ing taun lumaku|ALRN (Aileron Therapeutics Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Blueprint Medicines Corp BPMC|Wutah bathi saben saham ing taun lumaku GlycoMimetics, Inc. (GLYC)|SWTX (SpringWorks Therapeutics Inc.) - Tambahing bathi saben saham ing taun lumaku